These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6527255)

  • 21. Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes.
    Vincieri FF; Mazzi G; Papini P; Gelsomini N
    Farmaco Prat; 1986 Mar; 41(3):98-106. PubMed ID: 3709770
    [No Abstract]   [Full Text] [Related]  

  • 22. Stoichiometric model of alpha-cyclodextrin complex formation.
    Rosanske TW; Connors KA
    J Pharm Sci; 1980 May; 69(5):564-7. PubMed ID: 7381745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
    Green AR; Guillory JK
    J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
    Frank SG; Kavaliunas DR
    J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

  • 26. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases.
    Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H
    J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 28. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

  • 29. Spectral displacement techniques for studying the binding of spectroscopically transparent ligands to cyclodextrins.
    Selvidge LA; Eftink MR
    Anal Biochem; 1986 May; 154(2):400-8. PubMed ID: 3755301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclodextrins: a new group of industrial basic materials.
    Szejtli J
    Nahrung; 1985; 29(9):911-24. PubMed ID: 4079975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of association constants of beta-cyclodextrin and beta-cyclodextrin-bearing polymers with drugs by high-performance liquid chromatography.
    Sébille B; Thuaud N; Piquion J; Behar N
    J Chromatogr; 1987 Nov; 409():61-9. PubMed ID: 2826514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of water structure on cyclodextrin inclusion and light sensitivity of epinephrine].
    Hüttenrauch R; Fricke S; Knop M
    Pharmazie; 1985 Mar; 40(3):199-200. PubMed ID: 4023038
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract]   [Full Text] [Related]  

  • 35. Epimerization and racemization of some chiral drugs in the presence of cyclodextrin and liposomes.
    Aso Y; Yoshioka S; Takeda Y
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2786-9. PubMed ID: 2611938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution behavior of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone.
    Fukuda N; Higuchi N; Ohno M; Kenmochi H; Sekikawa H; Takada M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1366-9. PubMed ID: 3731351
    [No Abstract]   [Full Text] [Related]  

  • 37. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.
    Pitha J; Pitha J
    J Pharm Sci; 1985 Sep; 74(9):987-90. PubMed ID: 4067854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of a complex between the analgesic, 6-benzoyl-benzoxazolidinone (CERM 10194), and beta-cyclodextrin.
    Si-Nang L; Simond J; Schiff V; Trottier D; Pourrat A
    Pharm Acta Helv; 1985; 60(4):112-6. PubMed ID: 4011622
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of cyclodextrins in isotachophoresis. I. Effect of cyclodextrin on the isotachophoretic separation of related penicillins.
    Jelínek I; Snopek J; Smolková-Keulemansová E
    J Chromatogr; 1987 Sep; 405():379-84. PubMed ID: 3693475
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.